Woodard & CO Asset Management Group Inc Catalyst Biosciences, Inc. Transaction History

Woodard & CO Asset Management Group Inc

  • $414 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 01, 2019
SELL
$6.59 - $11.28 $26 - $45
-4 Closed
0 $0
Q4 2017

Feb 16, 2018
BUY
$4.52 - $13.69 $18 - $54
4
4 $0

Others Institutions Holding CBIO

# of Institutions
1
Shares Held
215
Call Options Held
0
Put Options Held
0
View Full List

About CATALYST BIOSCIENCES, INC.

CBIO Quotes by TradingView
  • Ticker CBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,477,100
  • Description
  • Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...
More about CBIO
Track This Portfolio

Track Woodard & CO Asset Management Group Inc Portfolio

Follow Woodard & CO Asset Management Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodard & CO Asset Management Group Inc , based on Form 13F filings with the SEC.

News

Stay updated on Woodard & CO Asset Management Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email